| Christine Adrienne Murray, MD | |
|
105 Westview Road, Suite 302, Colchester, VT 05446-8024 | |
| (802) 655-8888 | |
| (802) 985-2566 |
| Full Name | Christine Adrienne Murray |
|---|---|
| Gender | Female |
| Speciality | Obstetrics & Gynecology |
| Location | 105 Westview Road, Colchester, Vermont |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831103571 | NPI | - | NPPES |
| 0VN2039 | Medicaid | VT | |
| 01868840 | Other | NY | NY MEDICAID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 042-0009874 (Vermont) | Primary |
| 207VE0102X | Obstetrics & Gynecology - Reproductive Endocrinology | 042-0009874 (Vermont) | Secondary |
| Entity Name | Northeastern Reproductive Medicine Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982016689 PECOS PAC ID: 2365669736 Enrollment ID: O20140807001693 |
News Archive
Shire Canada Inc., a division of Shire plc, the global specialty biopharmaceutical company, is proud to announce that MEZAVANT® (mesalamine delayed and extended release tablets), the first and only once-daily mesalamine indicated for the induction of clinical and endoscopic remission in patients with mild-to-moderate, active ulcerative colitis (UC), has received an expanded indication to include maintenance of clinical and endoscopic remission (mucosal healing) in patients with ulcerative colitis.
Mathematicians are now developing completely new statistical calculations on the world's fastest computers in order to be able to predict how epidemics of dangerous hospital bacteria spread.
Children with attention problems in early childhood were 40 percent less likely to graduate from high school, says a new study from Duke University that examines how early childhood characteristics affect academic performance.
Two genes, each one of which is known to cause cancer on its own, together can lead to aggressive leukaemia. This is the conclusion from new research carried out on gene-modified mice at the Sahlgrenska Academy at the University of Gothenburg, Sweden. The discovery has surprised scientists, and may lead to new treatments.
NanoString Technologies, Inc., a privately held life sciences company marketing a complete solution for detecting and counting large sets of target molecules in biological samples, today announced a unique new product for miRNA analysis that includes a multiplexed assay for profiling the human miRNA transcriptome in a single tube. The company introduced the new assay kit, which expands the applications for its nCounter® Analysis System, at the American Association for Cancer Research annual meeting.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christine Adrienne Murray, MD 105 Westview Road, Suite 302, Colchester, VT 05446-8024 Ph: (802) 655-8888 | Christine Adrienne Murray, MD 105 Westview Road, Suite 302, Colchester, VT 05446-8024 Ph: (802) 655-8888 |
News Archive
Shire Canada Inc., a division of Shire plc, the global specialty biopharmaceutical company, is proud to announce that MEZAVANT® (mesalamine delayed and extended release tablets), the first and only once-daily mesalamine indicated for the induction of clinical and endoscopic remission in patients with mild-to-moderate, active ulcerative colitis (UC), has received an expanded indication to include maintenance of clinical and endoscopic remission (mucosal healing) in patients with ulcerative colitis.
Mathematicians are now developing completely new statistical calculations on the world's fastest computers in order to be able to predict how epidemics of dangerous hospital bacteria spread.
Children with attention problems in early childhood were 40 percent less likely to graduate from high school, says a new study from Duke University that examines how early childhood characteristics affect academic performance.
Two genes, each one of which is known to cause cancer on its own, together can lead to aggressive leukaemia. This is the conclusion from new research carried out on gene-modified mice at the Sahlgrenska Academy at the University of Gothenburg, Sweden. The discovery has surprised scientists, and may lead to new treatments.
NanoString Technologies, Inc., a privately held life sciences company marketing a complete solution for detecting and counting large sets of target molecules in biological samples, today announced a unique new product for miRNA analysis that includes a multiplexed assay for profiling the human miRNA transcriptome in a single tube. The company introduced the new assay kit, which expands the applications for its nCounter® Analysis System, at the American Association for Cancer Research annual meeting.
› Verified 3 days ago
Dr. Peter Raymond Casson, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 105 Westview Rd, Suite 302, Colchester, VT 05446 Phone: 802-655-8888 Fax: 802-985-2566 | |
Jennifer Keller Brown, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 105 Westview Rd, Suite 302, Colchester, VT 05446 Phone: 802-655-8888 Fax: 802-985-2566 |